TauRx Parses Subgroups to Make the Case for Methylene Blue Derivative, Again

I just added an edit to my old pro Methylene Blue post: Interesting Methylene Blue Dosing Story https://healthunlocked.com/cure-parkinsons/posts/edit/147878332

According to this paper, TauRx Parses Subgroups to Make the Case for Methylene Blue Derivative, Again https://www.alzforum.org/news/conference-coverage/taurx-parses-subgroups-make-case-methylene-blue-derivative-again some researchers are not really buying the effectiveness of LMTM (a stable reduced form of MB) for AD. Apparently this drug company goes through a lot of statistical and analytical gymnastics to find the silver lining in their trial results.

For the record, I have been off MB for over a month. I don't plan on re-starting it, but you never know.